Showing results (71-80 of 134) with videos related to
Sort By:
Pageof 14
American Journal of Physiology. Endocrinology and Metabolism|April 18, 2013
Glucagon-like peptide-1 receptor-mediated endosomal cAMP generation promotes glucose-stimulated insulin secretion in pancreatic β-cellsRamya S Kuna, Shravan Babu Girada, Suman Asalla, et al.Obesity Research|October 12, 2002
Hypophysectomy prevents ghrelin-induced adiposity and increases gastric ghrelin secretion in ratsMatthias Tschöp, David B Flora, John P Mayer, et al.Organic Letters|February 9, 2013
Concise synthetic routes to human insulinFa Liu, Ethan Y Luo, David B Flora, et al.Experimental Neurology|November 16, 2016
Novel GLP-1R/GIPR co-agonist "twincretin" is neuroprotective in cell and rodent models of mild traumatic brain injuryIan A Tamargo, Miaad Bader, Yazhou Li, et al.Experimental Neurology|November 16, 2019
Neurotrophic and neuroprotective effects of a monomeric GLP-1/GIP/Gcg receptor triagonist in cellular and rodent models of mild traumatic brain injuryYazhou Li, Elliot J Glotfelty, Inbar Namdar, et al.ACS Chemical Biology|October 14, 2010
A novel human-based receptor antagonist of sustained action reveals body weight control by endogenous GLP-1James T Patterson, Nickki Ottaway, Vasily M Gelfanov, et al.Bone|May 13, 2026
Semaglutide, at a dose that produces modest weight loss, induces mild suppression of bone remodeling in healthy control rats and those with chronic kidney diseaseMatthew R Allen, Corinne E Metzger, Neal X Chen, et al.Journal of Diabetes Science and Technology|December 7, 2010
In vitro and in vivo evaluation of native glucagon and glucagon analog (MAR-D28) during aging: lack of cytotoxicity and preservation of hyperglycemic effectW Kenneth Ward, Ryan G Massoud, Cory J Szybala, et al.Cardiovascular Diabetology|August 17, 2023
GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic diseaseStephan Sachs, Anna Götz, Brian Finan, et al.The Journal of Clinical Endocrinology and Metabolism|December 24, 2025
Sustained Action of Imapextide, a Glucagon-Like Peptide-1 Receptor Antagonist, in Healthy VolunteersElisa Fabbrini, Anastasiya Koshkina, Michael Hackett, et al.Pageof 14